Comparison of the performance of four screening tools for sarcopenia in patients with chronic liver disease

IF 2.9 3区医学 Q1 NURSING

International Journal of Nursing Sciences Pub Date : 2024-01-01 DOI:10.1016/j.ijnss.2023.12.014

Ting Yu , Shanshan Liu , Jing Zhao , Yan Jiang , Rong Deng

{"title":"Comparison of the performance of four screening tools for sarcopenia in patients with chronic liver disease","authors":"Ting Yu , Shanshan Liu , Jing Zhao , Yan Jiang , Rong Deng","doi":"10.1016/j.ijnss.2023.12.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Early identification of sarcopenia in patients with chronic liver disease is crucial for patient management and prevention of severe complications. We aimed to assess the effectiveness of Ishii score, Strength, Assistance with Walking, Rise from a Chair, Climb Stairs and Falls (SARC-F), SARC-F and Calf Circumference (SARC-CalF), and Mini Sarcopenia Risk Assessment-7 (MSRA-7) to screen sarcopenia in patients with chronic liver disease.</p></div><div><h3>Methods</h3><p>This prospective study included patients with chronic liver disease in the infectious department of a tertiary hospital in Sichuan, China. Ishii score, SARC-F, SARC-CalF, and MSRA-7 were used to screen for sarcopenia risk. Sarcopenia was diagnosed according to the Asian Myometriosis Working Group (AWGS) 2019, which was used as the gold standard to compare the performance of the four screening tools. We completed clinical registration on the Chinese Clinical Trial Registration website (ChiCTR2100043910).</p></div><div><h3>Results</h3><p>A total of 366 patients with chronic liver disease (22.4% women, mean age 48.96 ± 11.88 years) were evaluated. Based on the AWGS 2019 standard, the prevalence of sarcopenia in patients with chronic liver disease was 17.5%. Among all participants, receiver operating characteristic (ROC) produced an area under the curve (AUC) of 0.82 for Ishii score (sensitivity 85.94%, specificity 78.15%), 0.53 for SARC-F (sensitivity 6.25%, specificity 99.34%), 0.64 for SARC-CalF (sensitivity 45.31%, specificity 83.11%), and 0.55 for MSRA-7 (sensitivity 87.50%, specificity 22.85%). Based on AUC, decision curve analysis, and calibration curves, we concluded that Ishii score was the most accurate screening tool and was superior to the other tools.</p></div><div><h3>Conclusions</h3><p>Ishii score is more suitable for screening sarcopenia in patients with chronic liver disease than the SARC-F, SARC-CalF, and MSRA-7, based on the AWGS 2019 criteria. Nursing professionals can use Ishii score as a clinical tool to screen for sarcopenia in patients with chronic liver disease, providing an indication cue for the final diagnosis of sarcopenia, improving diagnostic efficiency, and enabling early identification and prevention of complications resulting from sarcopenia.</p></div>","PeriodicalId":37848,"journal":{"name":"International Journal of Nursing Sciences","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352013223001564/pdfft?md5=e46b15fa21b837e7fc2856e18846992b&pid=1-s2.0-S2352013223001564-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nursing Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352013223001564","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

Early identification of sarcopenia in patients with chronic liver disease is crucial for patient management and prevention of severe complications. We aimed to assess the effectiveness of Ishii score, Strength, Assistance with Walking, Rise from a Chair, Climb Stairs and Falls (SARC-F), SARC-F and Calf Circumference (SARC-CalF), and Mini Sarcopenia Risk Assessment-7 (MSRA-7) to screen sarcopenia in patients with chronic liver disease.

Methods

This prospective study included patients with chronic liver disease in the infectious department of a tertiary hospital in Sichuan, China. Ishii score, SARC-F, SARC-CalF, and MSRA-7 were used to screen for sarcopenia risk. Sarcopenia was diagnosed according to the Asian Myometriosis Working Group (AWGS) 2019, which was used as the gold standard to compare the performance of the four screening tools. We completed clinical registration on the Chinese Clinical Trial Registration website (ChiCTR2100043910).

Results

A total of 366 patients with chronic liver disease (22.4% women, mean age 48.96 ± 11.88 years) were evaluated. Based on the AWGS 2019 standard, the prevalence of sarcopenia in patients with chronic liver disease was 17.5%. Among all participants, receiver operating characteristic (ROC) produced an area under the curve (AUC) of 0.82 for Ishii score (sensitivity 85.94%, specificity 78.15%), 0.53 for SARC-F (sensitivity 6.25%, specificity 99.34%), 0.64 for SARC-CalF (sensitivity 45.31%, specificity 83.11%), and 0.55 for MSRA-7 (sensitivity 87.50%, specificity 22.85%). Based on AUC, decision curve analysis, and calibration curves, we concluded that Ishii score was the most accurate screening tool and was superior to the other tools.

Conclusions

Ishii score is more suitable for screening sarcopenia in patients with chronic liver disease than the SARC-F, SARC-CalF, and MSRA-7, based on the AWGS 2019 criteria. Nursing professionals can use Ishii score as a clinical tool to screen for sarcopenia in patients with chronic liver disease, providing an indication cue for the final diagnosis of sarcopenia, improving diagnostic efficiency, and enabling early identification and prevention of complications resulting from sarcopenia.

查看原文本刊更多论文

慢性肝病患者肌少症四种筛查工具的性能比较

目的及早发现慢性肝病患者的肌肉疏松症对于患者管理和预防严重并发症至关重要。我们旨在评估石井氏评分、力量、协助行走、从椅子上站起、爬楼梯和跌倒（SARC-F）、SARC-F 和小腿围度（SARC-CalF）以及迷你肌少症风险评估-7（MSRA-7）对筛查慢性肝病患者肌少症的有效性。采用石井氏评分、SARC-F、SARC-CalF 和 MSRA-7 来筛查肌少症风险。肌少症的诊断依据是亚洲子宫肌腺症工作组（AWGS）2019年的标准，该标准被用作比较四种筛查工具性能的金标准。我们在中国临床试验注册网站（ChiCTR2100043910）上完成了临床注册。结果共评估了366名慢性肝病患者（22.4%为女性，平均年龄（48.96 ± 11.88）岁）。根据 AWGS 2019 标准，慢性肝病患者的肌少症患病率为 17.5%。在所有参与者中，接收器操作特征（ROC）产生的曲线下面积（AUC）为：石井评分 0.82（灵敏度 85.94%，特异度 78.15%），SARC-F 0.53（灵敏度 6.25%，特异度 99.34%），SARC-CalF 0.64（灵敏度 45.31%，特异度 83.11%），MSRA-7 0.55（灵敏度 87.50%，特异度 22.85%）。结论根据 AWGS 2019 标准，石井评分比 SARC-F、SARC-CalF 和 MSRA-7 更适合筛查慢性肝病患者的肌少症。护理人员可将石井评分作为筛查慢性肝病患者肌少症的临床工具，为肌少症的最终诊断提供指征线索，提高诊断效率，及早发现和预防肌少症引起的并发症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Nursing Sciences Nursing-Nursing (all)

CiteScore

6.10

自引率

2.60%

发文量

408

审稿时长

25 days

期刊介绍： This journal aims to promote excellence in nursing and health care through the dissemination of the latest, evidence-based, peer-reviewed clinical information and original research, providing an international platform for exchanging knowledge, research findings and nursing practice experience. This journal covers a wide range of nursing topics such as advanced nursing practice, bio-psychosocial issues related to health, cultural perspectives, lifestyle change as a component of health promotion, chronic disease, including end-of-life care, family care giving. IJNSS publishes four issues per year in Jan/Apr/Jul/Oct. IJNSS intended readership includes practicing nurses in all spheres and at all levels who are committed to advancing practice and professional development on the basis of new knowledge and evidence; managers and senior members of the nursing; nurse educators and nursing students etc. IJNSS seeks to enrich insight into clinical need and the implications for nursing intervention and models of service delivery. Contributions are welcomed from other health professions on issues that have a direct impact on nursing practice.

文献相关原料

公司名称	产品信息	采购帮参考价格